• 2020 Date Announced: The 4th Annual US E-Cigarette Summit will take place May 4 2020

Dr. Nancy A. Rigotti, MD

Professor of Medicine, Harvard Medical School
Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston

Nancy Rigotti, MD, is an internationally known expert in tobacco use, tobacco cessation, and tobacco control public policy. Trained as a general internist, she is Associate Chief of the Division of General Internal Medicine at Massachusetts General Hospital, a Professor of Medicine at Harvard Medical School, and Past President of both the Society of General Internal Medicine and the Society for Research in Nicotine and Tobacco. Dr. Rigotti founded and directs the Tobacco Research and Treatment Center at Massachusetts General Hospital. This program combines a clinical service (MGH Tobacco Treatment Smoking Service) with a multidisciplinary research group whose mission is to develop innovative and effective smoking cessation treatment and tobacco control policy approaches.

Her research includes formal evaluations of the effects of tobacco control public policy and clinical and outcomes research studies testing behavioral and pharmacologic smoking cessation treatments. Her current research focuses on developing and testing systems that embed tobacco dependence treatment into the evolving U.S. health care delivery system, with a special interest in using hospitalization as an opportunity to promote tobacco cessation. Dr. Rigotti was a member of the committee that produced the 2018 U.S. National Academies of Science, Engineering, and Medicine’s  Report on the Public Health Consequences of Electronic Cigarettes.

Dr. Nancy A. Rigotti, MD will be speaking at:

Panel discussion and Q&A

- 12:05 - 12:35

The doctor’s dilemma: Providing guidance on e-cigarettes to adult smokers amid controversy and change

- 11:50 - 12:05

« Back to previous page